<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author>Латыпова, Г.Р.</author>
     <author>Хунафина, Д.Х.</author>
     <author>Валишин, Д.А.</author>
     <author>Галиева, А.Т.</author>
     <author>Галимов Р.Р.</author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
    </authors>
   </contributors>
   <titles>
    <title>ГИПЕРГОМОЦИСТЕИНЕМИЯ И СПОСОБЫ ЕЕ КОРРЕКЦИИ У ПАЦИЕНТОВ С ГЕМОРРАГИЧЕСКОЙ ЛИХОРАДКОЙ С ПОЧЕЧНЫМ СИНДРОМОМ</title>
   </titles>
   <dates>
    <year>2018</year>
    <pub-dates>
     <date>2021-02-04</date>
    </pub-dates>
   </dates>
   <journal>Сборник научных статей участников&#13;
Международной научно-практической конференции&#13;
г. Уфа&#13;
3-5 октября 2018 г.</journal>
   <abstract>The aim of the research was to curry out correction of&#13;
hyperhomocysteinemia in patients with hemorrhagic fever with renal failure&#13;
syndrome (HFRS) and evaluate some clinical and laboratory parameters. The&#13;
results of examining 91 men patients with HFRS at the age of 18 till 50 years old&#13;
are presented. The vitamin complex “Angiovit” was used for&#13;
hyperhomocysteinemia correction. The correction of hyperhomocysteinemia&#13;
using the vitamin complex in all the three considered forms (mid, severs, complicated) there are statistically significant decreases of homocysteine, the&#13;
duration of oliguric stage and the concentration of creatinine in oliguric and&#13;
diuretic stages in patients with HFRS compared with the group of patients having&#13;
the generally basically therapy.</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/1334</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/1504</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
